FDA inspection
Glaxo Operations U.K. Ltd.: FDA inspection ending Mar 16, 2023
FDA inspection 1211398 · Voluntary Action Indicated (VAI) · Barnard Castle
Key facts
| Inspection ID | 1211398 |
|---|---|
| Firm | Glaxo Operations U.K. Ltd. |
| FEI number | 3002807078 |
| Address | Harmire Road |
| City | Barnard Castle |
| Fiscal year | 2023 |
| Inspection end date | Mar 16, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data